News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Why Gilead Sciences, Inc. (GILD) And AbbVie (ABBV) Are Keeping An Eye On Achillion Pharmaceuticals, Inc. (ACHN)     12/15/2014
Merck & Co. (MRK),NewLink Genetics Ebola Trial Suspended After Patients Complain Of Joint Pain     12/12/2014
Bristol-Myers Squibb Company (BMY), Merck & Co. (MRK) Drugs Effective In Hodgkin Lymphoma Trials     12/9/2014
Isis Pharmaceuticals, Inc. (ISIS) Reports Positive Phase 2 Data For ISIS-FXI Rx For The Prevention Of Venous Thrombosis In Patients Undergoing Total Knee Replacement Surgery     12/8/2014
OncoSec Medical Inc. Says ImmunoPulse Tumor Drug Met Phase II Endpoints     12/5/2014
CytRx Corporation (CYTR) Receives Written FDA Communication Regarding Partial Clinical Hold For Aldoxorubicin Clinical Trials     12/4/2014
FDA Lifts Clinical Hold On Flexion Therapeutics (FLXN)'s FX006 For Osteoarthritis Pain     12/3/2014
Novartis AG (NVS) Fires Scientist Who Falsified Data In 6 Research Papers     12/1/2014
Momenta Pharmaceuticals, Inc. (MNTA)' Necuparanib Receives Fast Track Designation From The FDA For The Treatment Of Patients With Metastatic Pancreatic Cancer     12/1/2014
Dynavax Technologies Corporation (DVAX) Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline (GSK)     12/1/2014
Takeda Pharmaceuticals’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted Breakthrough Therapy Designation By U.S. FDA For Relapsed Or Refractory Systemic Light-Chain Amyloidosis     12/1/2014
Afferent Pharmaceuticals Clinical Data Demonstrating AF-219 Treatment Reduces Cough Frequency By 75% in Chronic Cough Is Published In The Lancet     11/25/2014
NeoStem, Inc.'s Stem Cell Therapy Fails Mid-Stage Heart Attack Study     11/19/2014
Cynapsus Therapeutics (CYNAF) Announces Positive Top-Line Results From CTH-105 Phase 2 Study Of APL-130277 For The Treatment Of OFF Episodes In Patients With Parkinson's Disease     11/19/2014
Merck & Co. (MRK) Announces Positive Study Investigating The Use Of KEYTRUDA® (pembrolizumab) Compared To Chemotherapy In Patients With Ipilimumab-Refractory Advanced Melanoma     11/17/2014

Featured Stories
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study     12/30/2010
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial     12/13/2010
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study     12/7/2010
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study     11/11/2010
American Association for Study of Liver Diseases: Early Study Shows HCV Vaccine Works, Scripps Clinic Study     11/3/2010
American Association for Study of Liver Diseases: Rapid Response for Once-Daily Protease Inhibitor, University of North Carolina Study     11/3/2010
American Academy of Ophthalmology: Glaucoma Drug Passes Early Clinical Test     10/21/2010
Ceregene, Inc. Initiates a New Controlled Phase 2b Trial of Cere-120 for Parkinson's Disease     10/19/2010
American Society for Bone and Mineral Research: Novel Drug Promising in Osteoporosis, University of Erlangen Study Reveals     10/19/2010
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression     10/19/2010
Ablynx (ABLYF) Opens Recruitment For First-In-Infant Phase 2a Study With Its Anti-Rsv Nanobody, ALX-0171     12/17/2014
Stemline Therapeutics, Inc. (STML) Initiates SL-401 Clinical Trial In Four Rare Myeloproliferative Neoplasms     12/17/2014
RXi Pharmaceuticals (RXII) Announces Sustained Effect Of RXI-109 At Three Months Post Scar Revision Surgery And The Completion Of Enrollment For Its Phase 2a Trial RXI-109-1301     12/17/2014
Pfizer (PFE) Initiates Phase 2 Study Of PF-06252616 In Duchenne Muscular Dystrophy     12/17/2014
Pivotal Therapeutics Inc. Release: VASCAZEN POMEGA Phase 2a Trial Protocol Cleared Clinical Evaluation By French FDA     12/17/2014
Velocity Pharmaceutical Development And Tigercat Pharma, Inc. Announce Phase 2 Results For VPD-737 In Patients With Chronic Pruritus     12/17/2014
First Patient Treated In Mapi Pharma's Phase 2a Clinical Trial Of GA Depot For Relapsing Remitting Multiple Sclerosis (RRMS)     12/17/2014
Poxel Announces Positive Top Line Results For Its Antidiabetic Agent Imeglimin In A Phase 2b Dose-Ranging Trial     12/17/2014
Neovacs SA Announces Top Line Phase 2b Clinical Trial Results Of TNF-Kinoid In Rheumatoid Arthritis And Update On Clinical Programs     12/16/2014
Anavex Life Sciences Corp. (AVXL.OB) Begins Enrollment Of Alzheimer's Patients In Phase 2a Clinical Trial Of ANAVEX 2-73 And ANAVEX PLUS     12/16/2014
SOV Therapeutics Announces Successful Phase 2b Study Of Oral Testosterone Undecanoate For Treatment Of Primary And Secondary Hypogonadism In Adult Males     12/16/2014
GENFIT Corp. (ALGFT): Gft505 Treatment Prevents Evolution To Cirrhosis     12/16/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Completion Of Patient Enrollment In The Rainier™ Clinical Trial Evaluating Apatorsen In Combination With ABRAXANEв Plus Gemcitabine In Patients With Metastatic Pancreatic Cancer     12/16/2014
Bone Therapeutics Confirms Safety In ALLOB® Phase 1/2a Trial For Delayed-Union Fractures     12/16/2014
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 1/2 Study Of ISIS-DMPK Rx In Patients With Myotonic Dystrophy Type 1     12/16/2014

More News
No News Posted on that date

Career Tips
What AstraZeneca PLC (AZN) Is Looking For In Hiring Scientists And Execs     12/5/2014
3 Cover Letter Mistakes You May Not Realize You've Made     12/4/2014
5 Myths About HR During The Job Inteview Debunked     12/4/2014
Avoid These 4 Common Resume Flaws     12/4/2014
Top 10 Biotech Careers Ranked     12/3/2014
Ardea Biosciences, Inc. HR VP Shares A Fool-Proof Guide To Joining A Startup     11/20/2014
3 Signs Your Resume Isn't Working     11/20/2014
3 Deadly Mistakes Made In Job Interviews     11/20/2014
4 Essentials Of A Good Cover Letter     11/20/2014
Sanofi (SAN.PA) And Incyte Corporation (INCY) Execs Exclusive: Future Hiring Trends And What They're Looking For In New Hires     11/7/2014
4 Common Mistakes That Sabotage Your Resume     11/6/2014
3 Tips To Capture The Hiring Manager's Interest In Seconds     11/6/2014
10 Shocking Job Search Blunders     11/6/2014
Eli Lilly (LLY) And Luminex (LMNX) Exclusive: Straight Talk From Career Experts On How To Get Hired     10/27/2014
Get The Inside Track: Hiring Tips From An Eli Lilly (LLY) HR Exec     10/23/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->